Advanced Orthobiologics Leading Growth in $1.6 Billion European Orthopedic Implant and Trauma Products Market, According to a New Analysis From Medtech Insight.NEWPORT BEACH, Calif. -- Medtech Insight, a division of Windhover wind·hov·er n. Chiefly British A kestrel. Information, announces the publication of a new Market & Technology Report entitled, "European Markets for Orthopedic Implants and Trauma Products," analyzing the French, German, Italian, Spanish and English markets for hip, knee, shoulder, and small joint reconstruction and replacement products, fracture fixation and bone growth stimulation Bone Growth Stimulation Definition Bone growth stimulation is the technique of promoting bone growth in difficult to heal fractures by applying a low electrical current or ultrasound to the fracture. , bone graft bone graft Orthopedic surgery Sterilized bony tissue, often of cadaveric origin, used to fill and/or 'sculpt' bone defects Indications Spinal fusion, revision of failed articular prostheses, filling traumatic or malignant bone defects, or periodontal defects. substitutes and growth factors, and bone cements. There is considerable potential for new and innovative technologies such as bone graft substitutes and resorbable implants in orthopedic trauma procedures in Europe. In 2004, the European orthopedic implants and trauma products market is expected to total more than $1.6 billion, and is expected to exceed $3 billion in 2008, driven by factors including surgeon acceptance of innovative new technologies with medical-based evidence, increased reimbursement for orthopedic products, the aging of the population, and patient demand for an improved quality of life. Although hip implants are the largest market segment overall in terms of sales Terms of sale Conditions under which a firm proposes to sell its goods or services for cash or credit. , the highest growth rate over the next few years in Europe is expected in advanced bone morphogenetic proteins (BMPs) and other orthobiologic agents such as allogenic-derived growth factors, blood-extracted growth factors, fibroblast growth factor Fibroblast growth factors, or FGFs, are a family of growth factors involved in wound healing and embryonic development. The FGFs are heparin-binding proteins and interactions with cell-surface associated heparan sulfate proteoglycans have been shown to be essential for FGF , gene therapy, recombinant platelet-derived growth factors platelet-derived growth factor n. A substance in platelets that is mitogenic for cells at the site of a wound, causing endothelial proliferation. , small molecule therapies, and stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young . Applications for these new products include fracture fixation, filling bony defects, and implant revision surgery, among others. These are among the findings of this comprehensive new 416-page report published by Medtech Insight, a division of Windhover Information. This report provides a thorough analysis for the following markets, from 2003 to 2008: hip, knee, shoulder, and small joint reconstruction and replacement products, fracture fixation and bone growth stimulation products, bone graft substitute and growth factor products, and bone cements. Eighteen detailed company profiles are also included, in addition to 184 exhibits. The European healthcare markets are also outlined, and an overview of bones and joints, and orthopedic implant materials is provided. Companies whose products and strategies are covered in the report include: B. Braun Melsungen B. Braun Melsungen AG is a German medical and pharmaceutical company, which has offices and facilities in 50 countries. Its headquarters are located in the small town of Melsungen, in central Germany. , Biomet, ConMed, Corin Group, Harvest Technologies, IsoTis OrthoBiologics, Johnson & Johnson, Orthofix International, OrthoLogic, Orthovita, Osteotech, Smith & Nephew, Stryker, Synthes, Tornier, Waldemar Link, Wright Medical Technology, and Zimmer, among others. A full table of contents for this report and ordering information can be viewed at http://www.medtechinsight.com/ReportA305.html. Recently acquired by Windhover Information Inc. (www.windhover.com), publisher of IN VIVO in vivo /in vi·vo/ (ve´vo) [L.] within the living body. in vi·vo adj. Within a living organism. in vivo adv. : The Business & Medicine Report and Start-UP: Windhover's Review of Emerging Technologies, Medtech Insight is a leading provider of business information for the medical technology marketplace. The company publishes the monthly "medtech insight" newsletter and a wide selection of comprehensive Market & Technology Reports, holds several medtech investment and partnering conferences annually, and provides custom consulting services. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion